Study on Sjögren's syndrome.

  • Gisela Mercedes Llamuca Cali Universidad Regional Autónoma de Los Andes
  • Luis Fernando Naranjo Ruiz Universidad Regional Autónoma de Los Andes
  • María Augusta Reyes Pérez Universidad Regional Autónoma de Los Andes
Keywords: Clinical and analytical data, syndrome, condition, ocular dryness, personalized treatment

Abstract

The research aims to understand Sjögren's syndrome as a rare condition, through a literature review. To carry out this research, its main purpose is to propose a clear, precise and concise definition of Sjögren's syndrome. There were several studies that have found the procedure for Sjögren's syndrome mutations, and several studies express that it has been evolving, and with it, reducing the risk of complications and recurrences. It was concluded that Sjögren's syndrome is based mainly on clinical and analytical data and can be diagnosed in the first moments of birth according to the manifestations observed in the case under study.

References

Fox, R., & Kang, H. (1992). Pathogenesis of Sjögren’s syndrome. Rheumatic Disease Clinics of North America, 18(3), 517-538. https://www.sciencedirect.com/science/article/abs/pii/S0889857X21003148

Guevara-Aguirre, J., Rosenbloom, A. L., Fielder, P. J., Diamond Jr, F. B., & Rosenfeld, R. G. (1993). Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. The Journal of Clinical Endocrinology & Metabolism, 76(2), 417-423.

Keret, R., Pertzelan, A., Zeharia, A., Zadik, Z., & Laron, Z. (1988). Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism. Israel journal of medical sciences, 24(2), 75-79.

Laron, Z., & Klinger, B. (1994). Laron syndrome: clinical features, molecular pathology and treatment. Hormone Research in Paediatrics, 42(4-5), 198-202. https://doi.org/10.1159/000184193

Laron, Z., Avitzur, Y., & Klinger, B. (1995). Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism, 44, 113-118. https://www.sciencedirect.com/science/article/abs/pii/0026049595902317

Laron, Z., Kauli, R., Lapkina, L., & Werner, H. (2017). IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Mutation Research/Reviews in Mutation Research, 772, 123-133. https://www.sciencedirect.com/science/article/pii/S1383574216300837

Ramírez López, L. R., Vinueza López, D. E., Jácome Sánchez, M. F., & Viteri Rodríguez, J. A. (2021). Enanismo tipo Laron, el síndrome con incidencia disminuida en diabetes y cáncer: revisión bibliográfica. Revista Universidad y Sociedad, 13(6), 548-554.

Published
2022-12-01